Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-21-033812

Director bought 727,272 shares at $11.00 ($7,999,992)

  • Director acquired 2,187,504 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Katabi Maha · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-18 Conversion : show line 1 in the form +2,187,504 2,187,504 I
2021-05-18 Purchase : show line 2 in the form +727,272 $11.00 $7,999,992 2,914,776 I
Open-market purchases · 727,272 sh · avg $11.00 · $7,999,992

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-18 Conversion : show line 3 in the form Series C Preferred Stock −2,187,504 0 I
Loading xslF345X03/doc4.xml…